Pretty sure i remember seeing this study a while back though but thanks for the reminder!
not sure why they are bothering though? It's high dose oral form and we all know about elmiron and pigmentary maculopathy etc Nd all the court cases..
Plus our patents would prohibit the use of pps in this area..
Who is supplying the PPS?
research reports and media, page-4107
-
- There are more pages in this discussion • 261 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.005(2.13%) |
Mkt cap ! $80.45M | |||
| Open | High | Low | Value | Volume |
| 23.8¢ | 24.0¢ | 23.0¢ | $124.1K | 527.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 32320 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 28026 | 2 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |